Personalizing induction therapy in kidney transplantation

被引:0
|
作者
Meredith J. Aull
Manikkam Suthanthiran
机构
[1] New York Presbyterian—Weill Cornell Medical College,Department of Surgery
[2] New York Presbyterian—Weill Cornell Medical College,Department of Medicine & Transplantation Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Induction therapy with rabbit anti-thymocyte globulin is preferable to induction with daclizumab in renal transplant recipients at high immunological risk. These findings provide additional support to the idea that personalized immunosuppressive regimens should be developed in renal transplant recipients.
引用
收藏
页码:619 / 620
页数:1
相关论文
共 50 条
  • [21] BK Viral Infection in Kidney Transplantation: The Role of Induction Therapy.
    Fischbach, B.
    Gonzalez, S.
    Yango, A.
    Chandrakantan, A.
    Rajagopal, A.
    Melton, L.
    Rice, K.
    Barri, Y.
    Saim, M.
    Allam, S.
    DiNubila, J.
    Levy, M.
    Klintmalm, G.
    TRANSPLANTATION, 2014, 98 : 559 - 559
  • [22] Kidney Transplantation Using Alemtuzumab Induction and Belatacept/Sirolimus Maintenance Therapy
    Kirk, A. D.
    Mehta, A. K.
    Guasch, A.
    Mead, S.
    Xu, H.
    Cheeseman, J.
    Horan, J.
    Kean, L.
    Larsen, C. P.
    Pearson, T. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 197 - 197
  • [23] Simultaneous pancreas/kidney transplantation without antibody therapy induction.
    Ciancio, G
    Burke, G
    Levi, D
    Roth, D
    Miller, J
    JOURNAL OF UROLOGY, 1998, 159 (05): : 185 - 185
  • [24] Efficacy and safety of antibody induction therapy in the current era of kidney transplantation
    Opelz, Gerhard
    Unterrainer, Christian
    Susal, Caner
    Doehler, Bernd
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (10) : 1730 - 1738
  • [25] Induction Therapy, HLA Mismatching, and Standard-Risk Kidney Transplantation
    Nassar, Mahmoud
    Elshafey, Mohammed
    Gonzalez, Carlos
    Nso, Nso
    Mahdi, Mamdouh
    Elsayed, Ingi
    AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (08) : 691 - 691
  • [26] INFECTIOUS COMPLICATIONS AFTER KIDNEY TRANSPLANTATION IN RELATION TO INDUCTION IMMUNOSUPPRESSIVE THERAPY
    Vnucak, Matej
    Granak, Karol
    Beliancinova, Monika
    Kleinova, Patricia
    Dedinska, Ivana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1236 - I1237
  • [27] Outcome of thymoglobulin induction therapy for cadaveric kidney transplantation in Blacks.
    Distant, D
    Maekell, MS
    Sumrani, N
    Alam, A
    Hong, J
    Woredekal, Y
    Qazi, Y
    Wolf, F
    Friedman, EA
    Salifu, MO
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 669A - 669A
  • [28] Single shot of alemtuzumab as induction therapy after kidney transplantation is sufficient
    Boesmueller, Claudia
    Sieb, Michael
    Pascher, Andreas
    Klempnauer, Juergen
    Muehlbacher, Ferdinand
    Strasak, Alexander
    Margreiter, Raimund
    TRANSPLANT INTERNATIONAL, 2011, 24 (11) : 1053 - 1058
  • [29] BK Viral Infection in Kidney Transplantation: The Role of Induction Therapy.
    Fischbach, B.
    Gonzalez, S.
    Yango, A.
    Chandrakantan, A.
    Rajagopal, A.
    Melton, L.
    Rice, K.
    Barri, Y.
    Saim, M.
    Allam, S.
    DiNubila, J.
    Levy, M.
    Klintmalm, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 559 - 559
  • [30] COST-EFFECTIVENESS OF BASILIXIMAB AS INDUCTION THERAPY FOR KIDNEY TRANSPLANTATION IN MEXICO
    Lemus, A.
    Jimenez Aranda, P.
    VALUE IN HEALTH, 2013, 16 (07) : A699 - A699